Current applications of molecular testing on body cavity fluids
D Pinto, F Schmitt - Diagnostic cytopathology, 2020 - Wiley Online Library
Introduction Effusion cytology has a high sensitivity for the diagnosis of malignancy and
provides abundant material for molecular testing. Effusion draining is a minimally invasive …
provides abundant material for molecular testing. Effusion draining is a minimally invasive …
Proceedings of the American Society of Cytopathology companion session at the 2019 United States and Canadian Academy of Pathology Annual meeting, part 2 …
We live in the “era” of minimally invasive procedures, molecular testing, and personalized
care. Effusions have a high sensitivity and will often yield diagnostic cytological material …
care. Effusions have a high sensitivity and will often yield diagnostic cytological material …
Application of the International System for Reporting Serous Fluid Cytopathology with cytohistological correlation and risk of malignancy assessment
A Pergaris, D Stefanou, P Keramari, S Sousouris… - Diagnostics, 2021 - mdpi.com
The International System for Reporting Serous Fluid Cytopathology (TIS) classifies serous
effusions into five categories: non-diagnostic (ND), negative for malignancy (NFM), atypia of …
effusions into five categories: non-diagnostic (ND), negative for malignancy (NFM), atypia of …
[HTML][HTML] Liquid biopsies using pleural effusion-derived exosomal DNA in advanced lung adenocarcinoma
Z Song, Z Cai, J Yan, YW Shao… - Translational Lung Cancer …, 2019 - ncbi.nlm.nih.gov
Background Recently, plasma-derived exosomal DNA (exoDNA) has been successfully
used in clinical genetic testing. However, the clinical utility of pleural effusion-derived …
used in clinical genetic testing. However, the clinical utility of pleural effusion-derived …
[HTML][HTML] Comprehensive genomic profiling of malignant effusions in patients with metastatic lung adenocarcinoma
SR Yang, CY Lin, H Stehr, SR Long, CS Kong… - The Journal of Molecular …, 2018 - Elsevier
Cytology samples are increasingly used for comprehensive molecular testing. Although fine-
needle aspirates are adequate substrates for high-throughput sequencing, the suitability of …
needle aspirates are adequate substrates for high-throughput sequencing, the suitability of …
[HTML][HTML] Epidermal growth factor receptor mutation frequency in squamous cell carcinoma and its diagnostic performance in cytological samples: a molecular and …
Background Epidermal growth factor receptor (EGFR) mutation is the most frequent mutation
tested in lung cancer for targeted therapy in the era of personalized medicine. Knowledge …
tested in lung cancer for targeted therapy in the era of personalized medicine. Knowledge …
A Combined test using both cell sediment and supernatant cell‐free DNA in pleural effusion shows increased sensitivity in detecting activating EGFR mutation in lung …
A Kawahara, C Fukumitsu, K Azuma, T Taira… - …, 2018 - Wiley Online Library
Introduction The aim of this study was to examine whether a combined test using both cell
sediment and supernatant cytology cell‐free DNA (ccf DNA) is more useful in detecting …
sediment and supernatant cytology cell‐free DNA (ccf DNA) is more useful in detecting …
Yield of malignant pleural effusion for detection of oncogenic driver mutations in lung adenocarcinoma
A DeMaio, JM Clarke, R Dash… - … of bronchology & …, 2019 - journals.lww.com
Background: Pleural fluid can be used to assess targetable mutations in patients with lung
adenocarcinoma. The primary objective of this study was to assess the yield of pleural fluid …
adenocarcinoma. The primary objective of this study was to assess the yield of pleural fluid …
Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor‐Mutant Lung Cancer
FJ Fintelmann, FM Troschel, MW Kuklinski… - The …, 2019 - academic.oup.com
Background Postprogression repeat biopsies are critical in caring for patients with lung
cancer with epidermal growth factor receptor (EGFR) mutations. However, hesitation about …
cancer with epidermal growth factor receptor (EGFR) mutations. However, hesitation about …
Cytologic investigations for the diagnosis of malignant pleural effusion in non–small cell lung cancer: state-of-the-art review for pulmonologists
S Shojaee, S Roy-Chowdhuri, J Safi… - Journal of Bronchology …, 2021 - journals.lww.com
Lung cancer is the current leading cause of cancer-related deaths worldwide, and malignant
pleural effusion, an indicator of the advanced stage of this disease, portends a poor …
pleural effusion, an indicator of the advanced stage of this disease, portends a poor …